Daily non-political popular news in brief.

Study finds drug spending caps cause some seniors to quit taking key medicines

09-11-2007 · EurekAlert!

Many seniors quit taking drugs for chronic illnesses such as diabetes and high blood pressure when they exceed their drug plan's yearly spending limits, according to a RAND Corp. study. The report, which examines the behavior of seniors enrolled in a private health plan, provides insight into how seniors may act under provisions of Medicare's new drug benefit plan that will leave about one-third of enrollees without drug coverage for some part of each benefit year.

Keywords: study, drug, spending, caps, cause, seniors, quit, taking, key, medicines, cap, senior, medicine

« Previous | Next »

Similar news on "Study finds drug spending caps cause some seniors to quit taking key medicines":

Physicians have cure for senior's medication bill woes
10-12-2006 · EurekAlert!
A recent study directed by Mount Sinai School of Medicine suggests that seniors with low incomes or no prescription coverage were less likely to use generic cardiovascular drugs than more affluent seniors and those with prescription drug coverage. The study, which appears in the October 2006 issue of the American Journal of Managed Care, is the first nationally representative study that examines the association of income and prescription drug coverage with generic medication use by Medicare beneficiaries.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »
Drug for cluster headaches may cause heart problems
08-13-2007 · EurekAlert!
A drug increasingly used to prevent cluster headaches can cause heart problems, according to a study published in the Aug. 14, 2007, issue of Neurology, the medical journal of the American Academy of Neurology. Those taking the drug verapamil for cluster headaches should be closely monitored with frequent electrocardiograms for potential development of irregular heartbeats.
Similar news · Read more »
Cigarette smoke, alcohol damage hearts worse as combo
11-21-2007 · EurekAlert!
A new study shows that taking in smoky air and drinking alcohol basically nullify any potential heart benefit from drinking alcohol by itself. Researchers at the University of Alabama at Birmingham found that mice exposed to smoky air and fed a liquid diet containing ethanol, the intoxicating ingredient in alcohol, had a 4.7-fold increase in artery lesions, a key sign of advancing heart disease. The study appears in Free Radical Biology & Medicine.
Similar news · Read more »
Common preterm labor drug has more side effects than alternative
06-29-2007 · EurekAlert!
The drug most commonly used to arrest preterm labor, magnesium sulfate, is more likely than another common treatment to cause mild to serious side effects in pregnant women, according to a study from researchers at Lucile Packard Children's Hospital and Stanford University School of Medicine.
Similar news · Read more »
World AIDS Day: HIV prevention, diagnosis and treatment
11-30-2007 · EurekAlert!
On December 1, PLoS Medicine is publishing a collection of research articles and commentary, as well as an editorial to mark World AIDS Day 2007. In this release: Men who have sex with men face high AIDS risk in developing countries; Women disclose their HIV status at three key times around childbirth; Unnoticed mutation in AIDS virus can cause drug resistance; and HIV confirmatory test can also estimate recent infections.
Similar news · Read more »
Study proves the co-pay connection in chronic disease
01-08-2008 · EurekAlert!
As 2008 begins, millions of Americans are facing higher insurance co-pays for drugs and doctor appointments. But a new study finds that instead of going up, co-pays should go down -- at least for some people taking some drugs. For people with chronic diseases, a few dollars can make all the difference when deciding to buy key preventive medicines.
Similar news · Read more »
War-injured boy inspired new Marshall Scholar
12-04-2007 · Massachusetts Institute of Technology (MIT)
Ali Alhassani, an MIT senior who discovered his passion for medicine through the friendship of a war-injured Iraqi boy, has been awarded a Marshall Scholarship, and will study health policy, planning and financing in London.
Similar news · Read more »
UT Southwestern participating in nationwide study on leading cause of vision loss for seniors
10-24-2006 · EurekAlert!
UT Southwestern Medical Center is participating in a nationwide study investigating whether modified combinations of vitamins, minerals and fish oil products can slow the progression of vision loss from age-related macular degeneration.
Similar news · Read more »
Targeting tau: Inflammation study suggests new approach for fighting Alzheimer's
02-01-2007 · EurekAlert!
Researchers at the University of Pennsylvania School of Medicine have shown that impaired function and loss of synapses in the hippocampus of a mouse form of Alzheimer's disease (AD) is related to the activation of immune cells called microglia, which cause inflammation. These events precede the formation of tangles -- twisted fibers of tau protein that build up inside nerve cells -- a hallmark of advanced AD.
Similar news · Read more »